养血润肠方口服治疗结肠慢传输型便秘的临床疗效  被引量:1

Clinical Therapeutic Effect of Oral Enriching Blood and Moistening Bowel Formula in the Treatment of Colon Slow Transit Constipation

在线阅读下载全文

作  者:须海丰 龚建明[1] 范建明[1] 徐琴[1] 顾俊[1] 

机构地区:[1]江苏省太仓市中医医院肛肠科,江苏太仓215400

出  处:《中国肛肠病杂志》2012年第4期40-42,共3页Chinese Journal of Coloproctology

摘  要:为探讨养血润肠方口服治疗结肠慢传输型便秘(STC)的临床疗效,本研究将63例结肠STC患者随机分为治疗组(32例)和对照组(31例),治疗组患者口服养血润肠方治疗,对照组口服六味安消胶囊治疗,两组均以4周为一疗程。结果显示,(1)疗效:治疗组治愈15例,显效11例,有效4例,无效2例,总有效率为93.8%(30/32);对照组治愈12例,显效9例,有效4例,无效6例,总有效率为80.6%(25/31)。治疗组总有效率明显高于对照组,P〈0.05。(2)复发:半年后随访,治疗组复发3例(9.4%),对照组复发6例(19.4%)。治疗组复发率明显低于对照组,P〈0.05。结果表明,养血润肠方治疗结肠STC疗效满意,复发率低,值得临床推广应用。The objective of this study was to investigate the clinical effect of oral enriching blood and mois- tening bowel formula(EBMBF) in the treatment of colon slow transit constipation(STC). The 63 patients with colon STC were randomly divided into treatment group(32 cases) and control group(31 cases);treat- ment group was orally given with EBMBF, control group with Liuwei anxiao capsule, the treatment course of both groups all took 4 weeks. As results, (1)therapeutic effect:in treatment group 15 cases were cured, 11 cases excellent, 4 cases response, 2 cases non-response, and total effective rate was 93.8 〈 (30/32) ~ in control group, 12,9,4,6, and 80.6〈 (25/31) respectively, apparently, the total effective rate of treatment group was significantly higher than that of control group( P 〈0.05) ; (2)recurrence:the follow-up later 0. 5 year after treatment found 3 cases of treatment group being recurrent(9.4%),6 cases of control group being recurrent(19.4%) ,the former was significantly lower than the latter( P 〈0.05). Results show that above-mentioned formula in the treatment of STC is of satisfactory therapeutic effect and lower recurrence rate,worthy to be popularized to use clinically.

关 键 词:结肠慢传输型便秘 养血润肠方 疗效 

分 类 号:R574.62[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象